Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-21

Clinical Trial Update: PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes

View source ↗

Summary

The PROMASTER prospective cohort study investigating stratification and extreme response mechanisms in diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Diabetes | Status: COMPLETED